Incidence and clinical characteristics of pediatric-onset type 2 diabetes in Hong Kong: The Hong Kong childhood diabetes registry 2008 to 2017
- PMID: 33978300
- DOI: 10.1111/pedi.13231
Incidence and clinical characteristics of pediatric-onset type 2 diabetes in Hong Kong: The Hong Kong childhood diabetes registry 2008 to 2017
Abstract
Objective: With increasing prevalence of childhood obesity worldwide, the incidence of pediatric-onset type 2 diabetes (T2D) is also increasing in many countries. We aim to analyze the time trend and incidence of T2D in children in Hong Kong from 2008 to 2017, and to characterize clinical characteristics at diagnosis.
Methods: Data were retrieved from the Hong Kong Childhood Diabetes Registry. All children with T2D diagnosed at the age of less than 18 years from January 1, 2008 to December 31, 2017 and managed in the public health care system were included in this study.
Results: In the incident years of 2008-2017 period, 391 children were diagnosed with T2D. The crude incidence rate was 3.42 per 100,000 persons/year [95% confidence interval (CI) 3.08-3.76], which was much higher than that in last registry of 1.27 per 100,000 persons/year in 1997-2007 (P < 0.001).Most children (76%) were asymptomatic and were diagnosed by routine screening. At presentation, a significant proportion presented with co-morbidities including fatty liver (37.9%), dyslipidaemia (35.3%), hypertension (22.5%), and microalbuminuria (12.8%).
Conclusions: The incidence of T2D in children has increased significantly in Hong Kong. Most of them were asymptomatic and picked up on routine health screening. Yet, comorbidities were commonly identified at diagnosis.
Keywords: Hong Kong; childhood diabetes registry; epidemiology; incidence; pediatrics; type 2 diabetes mellitus.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778-1786. https://doi.org/10.1001/jama.2014.3201.
-
- Bobo N, Evert A, Gallivan J, et al. An update on type 2 diabetes in youth from the National Diabetes Education Program. Pediatrics. 2004;114(1):259-263. https://doi.org/10.1542/peds.114.1.259.
-
- TODAY Study Group: Silva Arslanian, Pyle L, Washington G, et al. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care. 2013;36:1749-1757. https://doi.org/10.2337/dc12-2393.
-
- TODAY Study Group: Jane Lynch, El L, Fisher L, et al. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36:1735-1741. https://doi.org/10.2337/dc12-2420.
-
- TODAY Study Group: Ruth S Weinstock, Caprio S, Copeland KC, et al. Lipid and inflammatory cardiovascular risk worsens over 3years in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36:1758-1764. https://doi.org/10.2337/dc12-2388.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical